MICK, by Sequentia Biotech

An accurate automated platform to analyse microbiome raw data in real time, to help healthcare professionals in integrating microbiome analysis into clinical practice.

Dysbiosis (the imbalance of the microbial community that resides within and upon us) can affect health and represents a risk factor for the genesis and evolution of a plethora of chronic diseases and pathologies. Surprisingly, it counts for an estimated 86% of the overall deaths and 77% of the disease burden in Europe.

The analysis of the microbiome is necessary to detect, assess and monitor it. Nevertheless, microbiome analysis and its application to the clinical field is very complex, expensive and time-consuming.

MICK is the first digital decision support system to help healthcare professionals in integrating microbiome analysis into clinical practice. MICK automated platform analyses microbiome raw data in real time, with the highest accuracy and translates it into evidence-based analytics, insights, and practical recommendations.

logo sequentia biotech BN

Link Cordis (still not available)

¿Tienes un proyecto innovador?

$